Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Scinai Immunotherapeutics Ltd ADR (SCNI)

Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,900
  • Shares Outstanding, K 853
  • Annual Sales, $ 0 K
  • Annual Income, $ -6,500 K
  • EBIT $ -6 M
  • EBITDA $ -6 M
  • 60-Month Beta 2.43
  • Price/Sales 6.42
  • Price/Cash Flow N/A
  • Price/Book 0.66

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.94 +15.65%
on 11/21/24
3.75 -9.35%
on 11/27/24
+0.47 (+16.04%)
since 11/20/24
3-Month
2.70 +25.93%
on 11/19/24
4.14 -17.87%
on 09/26/24
-0.16 (-4.49%)
since 09/20/24
52-Week
2.23 +52.47%
on 06/10/24
8.92 -61.88%
on 07/15/24
-3.60 (-51.43%)
since 12/20/23

Most Recent Stories

More News
Scinai Immunotherapeutics (NASDAQ: SCNI) Expands CDMO Operations with New U.S. Subsidiary

Scinai Immunotherapeutics (NASDAQ: SCNI) has established a U.S.-based subsidiary, Scinai Bioservices Inc., to enhance its Contract Development and Manufacturing Organization (CDMO) operations and address...

SCNI : 3.40 (+0.89%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Announces Strategic Board Appointment

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company specializing in the development of inflammation and immunology (“I&I”) biological products and offering CDMO services through its...

SCNI : 3.40 (+0.89%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Welcomes Dr. Jonathan Sadeh to Scientific Advisory Board

Scinai Immunotherapeutics (NASDAQ: SCNI) has appointed Dr. Jonathan Sadeh to its Scientific Advisory Board, where he will support the advancement of the company’s IL-17 program and VHH antibody pipeline....

SCNI : 3.40 (+0.89%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Reports Nine-Month Financial Results

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing innovative biological products targeting inflammation and immunology (“I&I”) and offering contract development...

SCNI : 3.40 (+0.89%)
Scinai Immunotherapeutics (NASDAQ: SCNI) to Spotlight I&I Pipeline, CDMO Services at BIO-Europe 2024

Scinai Immunotherapeutics (NASDAQ: SCNI) will showcase its inflammation and immunology (“I&I”) product pipeline and contract development and manufacturing (“CDMO”) services at the BIO-Europe 2024...

SCNI : 3.40 (+0.89%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Schedules Virtual Panel Discussion

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices...

SCNI : 3.40 (+0.89%)
Scinai Immunotherapeutics (NASDAQ: SCNI) CEO Featured on Latest Episode of BioMedWire Podcast

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing...

SCNI : 3.40 (+0.89%)
Scinai Immunotherapeutics (NASDAQ: SCNI), EIB Close on Loan Restructuring Agreement

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing...

SCNI : 3.40 (+0.89%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Enters Into $2M Investment Commitment Agreement

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices...

SCNI : 3.40 (+0.89%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Reports Q2 2024 Financial Results

Scinai Immunotherapeutics (NASDAQ: SCNI) is a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai...

SCNI : 3.40 (+0.89%)

Business Summary

Scinai Immunotherapeutics Ltd. is a biopharmaceutical company focused on developing, manufacturing, and commercializing inflammation and immunology biological products primarily for the treatment of autoimmune and infectious diseases. Scinai Immunotherapeutics Ltd., formerly known as BiondVax Pharmaceuticals...

See More

Key Turning Points

3rd Resistance Point 3.63
2nd Resistance Point 3.57
1st Resistance Point 3.48
Last Price 3.40
1st Support Level 3.33
2nd Support Level 3.27
3rd Support Level 3.18

See More

52-Week High 8.92
Fibonacci 61.8% 6.36
Fibonacci 50% 5.57
Fibonacci 38.2% 4.79
Last Price 3.40
52-Week Low 2.23

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar